|
1.
Gary Stroy Takes Helm At Neurostim Co. Neuralieve File Format: PDF/Adobe Acrobat - View as HTML Stroy said that he had the experience that Neuralieve was seeking in its first ... equity of Neuralieve, Stroy said. Neuralieve has an exclusive license to ... 2.
Draft Press Release Re: World Melanoma Conference File Format: PDF/Adobe Acrobat - View as HTML Sep 7, 2006 ... Media and Investor Contact:. Courtney Harris. Feinstein Kean Healthcare. 617-761-6744 courtney.harris@fkhealth.com. IMMEDIATE RELEASE ... 3.
Asterand Announces New Test to Reduce Risks in Human Drug Trials File Format: PDF/Adobe Acrobat - View as HTML to help drug companies test their drug candidates thoroughly so that they can put them into the clinic with increased confidence," said Asterand CEO, ... 4.
PRONAI ANNOUNCES DNA INTERFERENCE (DNAI®) DRUG DEVELOPMENT ... File Format: PDF/Adobe Acrobat - View as HTML company pioneering a new class of nucleic-acid drugs based on DNA interference (DNAi®), today announced its drug development strategy for 2007, ... 5.
Asterand Announces New Test to Reduce Risks in Human Drug Trials File Format: PDF/Adobe Acrobat - View as HTML possibly happened with the drug in the recent British trial. "Until now tests to detect the reaction to antibody drug candidates have been difficult to ... 6.
Pharmagene plc File Format: PDF/Adobe Acrobat - View as HTML Sep 19, 2005 ... Pharmagene, the UK listed human tissue based drug discovery company, announces that it has agreed the terms of a ... 7.
Gary Stroy Takes Helm At Neurostim Co. Neuralieve File Format: PDF/Adobe Acrobat - View as HTML Recently moved to Sunnyvale, Calif., Neuralieve is a spin-out of NeuroPace Inc., a neurostim company combating epilepsy based in Mountain View, Calif. ... 8.
Apjohn Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan ... Apjohn Ventures : 269-349-8999 : 350 E. Michigan Avenue : Suite 500 ... 9.
PRONAI ANNOUNCES DNA INTERFERENCE (DNAI®) DRUG DEVELOPMENT ... File Format: PDF/Adobe Acrobat - View as HTML company pioneering a new class of nucleic-acid drugs based on DNA interference (DNAi®), today announced its drug development strategy for 2007, ... 10.
Detroit’s Asterand voted best place to work for scientists File Format: PDF/Adobe Acrobat - View as HTML Detroit’s Asterand voted best place to work for scientists. June 9, 2005. Detroit, MI June 9, 2005: Asterand, the Detroit-based tissue banking company, ... |
